Press release
-
Palo Alto Research Center (PARC) to join SRI International
Signaling a new chapter for Silicon Valley, two veteran R&D leaders are combining minds to advance and accelerate world-changing science and technology.
-
SRI International appoints Kathlynn Brown to Biosciences Division President
The SRI International veteran to expand leadership for the innovations needed to cure diseases and improve people’s health.
-
SRI International spearheads two groundbreaking efforts to secure 5G
Deep-tech pioneer addresses 5G network security by leveraging its unique intellectual property and research, extensive experience and relationships with its spinout companies
-
SRI International launches commercialization group, announces new president
Suresh Sunderrajan to lead, define and accelerate SRI’s commercialization opportunities.
-
SRI International expanding BioCyc database collection for genomic researchers
BioCyc database reaches 20,000 genomes ahead of collaboration with Wolters Kluwer.
-
SRI International developing first-ever quantum manufacturing technology roadmap
SRI and QED-C to leverage team of industry, national lab and academic partners to develop roadmap.
-
SRI Ventures announces new spin-out, Confidencial, to secure sensitive information and collaboration for distributed enterprises
Confidencial secures seed funding to add privacy-preserving cryptographic tech to existing business applications.
-
SRI International announces investment in Prevasio
Security administrators can now secure cloud infrastructure with SRI AI technology.
-
SRI awarded $23 million contract for education research partnerships across Kentucky, Tennessee, Virginia and West Virginia
SRI Education has been awarded a five year contract to fund the continued leadership of the Regional Educational Laboratory (REL) Appalachia.
-
SRI International announces collaboration agreement with Janssen
Collaboration focuses on SRI’s Synfini artificial intelligence and automation platform to accelerate small-molecule drug discovery.
-
Nomura-SRI Innovation Center welcomes new members and plans to increase membership in 2022
The Nomura-SRI innovation center (NSIC) announced today that they will be welcoming several major member additions.
-
SRI Bioscience awarded $14.7 million contract to continue development of high-concentration Naloxone formulation
SRI Biosciences has been awarded a contract sponsored by the Defense Threat Reduction Agency (DTRA) to continue development of a high-concentration naloxone product.